• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

外周动脉疾病：2010年至2020年巴西公共卫生系统中紧急开放血管重建术与血管腔内血管重建术的比较

Peripheral artery disease: a comparison of urgent open and endovascular revascularizations on the public health system in Brazil, from 2010 to 2020.

作者信息

Magalhães Thaís Rodrigues, Fernandes Daniel César Magalhães, Gomide Roberto, Nakano Hideki, Afiune André Vespasiano, Silva Rômulo Mendes, Moreira Paulo Ricardo Alves, de Sousa Lima Rosa Tanmirys

机构信息

Hospital Geral de Goiânia Dr. Alberto Rassi - HGG, Goiânia, GO, Brasil.

出版信息

J Vasc Bras. 2022 Jul 29;21:e20220016. doi: 10.1590/1677-5449.202200161. eCollection 2022.

DOI:10.1590/1677-5449.202200161
PMID:35975182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9351983/
Abstract

BACKGROUND

Peripheral artery disease (PAD) has high prevalence and is associated with high risk of cardiovascular events. Surgical or endovascular intervention is necessary in chronic limb-threatening ischemia.

OBJECTIVES

To evaluate the distribution of open and endovascular revascularizations in different regions of Brazil, analyzing the health system costs and mortality related to these procedures.

METHODS

A descriptive, cross-sectional, observational, epidemiological study was carried out to evaluate open and endovascular surgeries performed on the SUS public healthcare system in Brazil, from 2010 to 2020. Data were collected from the SUS Department of Informatics (Datasus).

RESULTS

Over the period analyzed, 83,218 admissions for open and endovascular surgeries were registered, with a total cost of R$ 333,989,523.17. There were more hospital admissions for percutaneous procedures (56,132) than for conventional surgery (27,086). Most of the procedures (83%) were performed in the country's Southeast and South regions, while the North region had the lowest number of procedures. Over the period evaluated, there was a decreasing trend for open procedures and an increasing trend for endovascular procedures. The average hospital stay was shorter for endovascular procedures (5.3 days) than for open surgery (10.2 days). The analysis of mortality related to these procedures revealed a higher rate of in-hospital mortality associated with open revascularization than with endovascular (5.24% vs. 1.56%).

CONCLUSIONS

Endovascular techniques constituted the primary approach for revascularization treatment in critical limb-threatening ischemia, with a lower in-hospital mortality rate and shorter hospital stay when compared to open surgeries.

摘要

背景

外周动脉疾病（PAD）患病率高，且与心血管事件的高风险相关。对于慢性肢体威胁性缺血，手术或血管内介入治疗是必要的。

目的

评估巴西不同地区开放和血管内血运重建术的分布情况，分析与这些手术相关的卫生系统成本和死亡率。

方法

开展了一项描述性、横断面、观察性流行病学研究，以评估2010年至2020年在巴西统一卫生系统（SUS）公共医疗系统中进行的开放和血管内手术。数据从SUS信息部（Datasus）收集。

结果

在分析的时间段内，登记了83218例开放和血管内手术入院病例，总成本为333989523.17雷亚尔。经皮手术的住院病例数（56132例）多于传统手术（27086例）。大多数手术（83%）在该国东南部和南部地区进行，而北部地区的手术数量最少。在评估期间，开放手术呈下降趋势，血管内手术呈上升趋势。血管内手术的平均住院时间（5.3天）比开放手术（10.2天）短。对与这些手术相关的死亡率分析显示，开放血运重建术的院内死亡率高于血管内手术（5.24%对1.56%）。

结论

血管内技术是严重肢体威胁性缺血血运重建治疗的主要方法，与开放手术相比，院内死亡率更低，住院时间更短。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/3f45c4475d6f/jvb-21-e20220016-g08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/1de93e49c67b/jvb-21-e20220016-g01-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/3fda22660701/jvb-21-e20220016-g02-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/3ad5159021de/jvb-21-e20220016-g03-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/3402468e1b6c/jvb-21-e20220016-g04-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/1f58b1426752/jvb-21-e20220016-g05-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/c908e1eed234/jvb-21-e20220016-g06-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/418baf00fb7f/jvb-21-e20220016-g07-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/95ab72e3ef54/jvb-21-e20220016-g08-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/d176e99fdc5a/jvb-21-e20220016-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/1f14cc22ef57/jvb-21-e20220016-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/f90d1dd730a4/jvb-21-e20220016-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/0360f3ba0c5e/jvb-21-e20220016-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/240d2338be6f/jvb-21-e20220016-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/4353afeb563b/jvb-21-e20220016-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/1415361c238b/jvb-21-e20220016-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/3f45c4475d6f/jvb-21-e20220016-g08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/1de93e49c67b/jvb-21-e20220016-g01-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/3fda22660701/jvb-21-e20220016-g02-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/3ad5159021de/jvb-21-e20220016-g03-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/3402468e1b6c/jvb-21-e20220016-g04-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/1f58b1426752/jvb-21-e20220016-g05-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/c908e1eed234/jvb-21-e20220016-g06-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/418baf00fb7f/jvb-21-e20220016-g07-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/95ab72e3ef54/jvb-21-e20220016-g08-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/d176e99fdc5a/jvb-21-e20220016-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/1f14cc22ef57/jvb-21-e20220016-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/f90d1dd730a4/jvb-21-e20220016-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/0360f3ba0c5e/jvb-21-e20220016-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/240d2338be6f/jvb-21-e20220016-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/4353afeb563b/jvb-21-e20220016-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/1415361c238b/jvb-21-e20220016-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9351983/3f45c4475d6f/jvb-21-e20220016-g08.jpg

相似文献

1
Peripheral artery disease: a comparison of urgent open and endovascular revascularizations on the public health system in Brazil, from 2010 to 2020.外周动脉疾病：2010年至2020年巴西公共卫生系统中紧急开放血管重建术与血管腔内血管重建术的比较
J Vasc Bras. 2022 Jul 29;21:e20220016. doi: 10.1590/1677-5449.202200161. eCollection 2022.
2
Lower Limb Revascularization for Peripheral Arterial Disease in 10,951 Procedures over 11 years in a Public Health System: A Descriptive Analysis of the Largest Brazilian City.11 年间在公共卫生系统中 10951 例下肢血运重建术治疗外周动脉疾病：巴西最大城市的描述性分析。
Ann Vasc Surg. 2021 Jan;70:223-229. doi: 10.1016/j.avsg.2020.07.026. Epub 2020 Aug 8.
3
Surgical repair of abdominal aortic aneurysms on the public health system in the largest city in Brazil: a descriptive analysis of in-hospital data on 2693 procedures over 10 years.巴西最大城市公共卫生系统中腹主动脉瘤的外科修复：对10年间2693例手术的院内数据进行描述性分析。
J Vasc Bras. 2022 Aug 15;21:e20210087. doi: 10.1590/1677-5449.202100872. eCollection 2022.
4
Epidemiological analysis of lower limb revascularization for peripheral arterial disease over 12 years on the public healthcare system in Brazil.巴西公共医疗体系中12年来外周动脉疾病下肢血管重建术的流行病学分析。
J Vasc Bras. 2022 Sep 2;21:e20210215. doi: 10.1590/1677-5449.202102152. eCollection 2022.
5
Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.下肢外周动脉疾病的支架置入术：一项基于证据的分析。
Ont Health Technol Assess Ser. 2010;10(18):1-88. Epub 2010 Sep 1.
6
Nationwide Trends of Hospital Admission and Outcomes Among Critical Limb Ischemia Patients: From 2003-2011.全国范围内重症肢体缺血患者住院和结局的趋势：2003-2011 年。
J Am Coll Cardiol. 2016 Apr 26;67(16):1901-13. doi: 10.1016/j.jacc.2016.02.040. Epub 2016 Mar 21.
7
Risk factors for readmission after lower extremity procedures for peripheral artery disease.下肢动脉疾病外周血管手术后再入院的风险因素。
J Vasc Surg. 2013 Jul;58(1):90-7.e1-4. doi: 10.1016/j.jvs.2012.12.031. Epub 2013 Mar 29.
8
Endovascular Versus Surgical Revascularization for Chronic Mesenteric Ischemia: Insights From the National Inpatient Sample Database.腔内与手术血管重建治疗慢性肠系膜缺血：来自国家住院患者样本数据库的见解。
JACC Cardiovasc Interv. 2017 Dec 11;10(23):2440-2447. doi: 10.1016/j.jcin.2017.09.033.
9
Epidemiological insights into thoracic and lumbar sympathectomies in Brazil: a comparative analysis of open versus video-assisted procedures.巴西胸腔和腰椎交感神经切除术的流行病学见解：开放式与视频辅助手术的比较分析。
Acta Cir Bras. 2024 Oct 7;39:e397124. doi: 10.1590/acb397124. eCollection 2024.
10
Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease.单纯与复合杂交血运重建术在下肢症状性闭塞性疾病中的作用。
J Vasc Surg. 2010 Jun;51(6):1425-1435.e1. doi: 10.1016/j.jvs.2010.01.092.

引用本文的文献

1
Vascular rehabilitation interventions in people with peripheral arterial disease: an integrative review.外周动脉疾病患者的血管康复干预：一项综合综述。
J Vasc Bras. 2025 Mar 14;24:e20240088. doi: 10.1590/1677-5449.202400882. eCollection 2025.
2
Differences between Lower Extremity Arterial Occlusion vs. Stenosis and Predictors of Successful Endovascular Interventions.下肢动脉闭塞与狭窄的区别，以及血管内介入治疗成功的预测因素。
Medicina (Kaunas). 2023 Nov 17;59(11):2029. doi: 10.3390/medicina59112029.

本文引用的文献

1
Epidemiology and Risk of Amputation in Patients With Diabetes Mellitus and Peripheral Artery Disease.糖尿病合并外周动脉疾病患者的截肢流行病学和风险。
Arterioscler Thromb Vasc Biol. 2020 Aug;40(8):1808-1817. doi: 10.1161/ATVBAHA.120.314595. Epub 2020 Jun 25.
2
Comparison Between Endovascular and Open Surgery for the Treatment of Peripheral Artery Diseases: A Meta-Analysis.血管内介入治疗与开放手术治疗外周动脉疾病的比较：一项荟萃分析。
Ann Vasc Surg. 2020 Jan;62:484-495. doi: 10.1016/j.avsg.2019.06.039. Epub 2019 Aug 30.
3
Global vascular guidelines on the management of chronic limb-threatening ischemia.
全球血管指南：慢性肢体威胁性缺血的管理。
J Vasc Surg. 2019 Jun;69(6S):3S-125S.e40. doi: 10.1016/j.jvs.2019.02.016. Epub 2019 May 28.
4
The BEST-CLI trial is nearing the finish line and promises to be worth the wait.BEST-CLI 试验即将接近尾声，值得我们期待。
J Vasc Surg. 2019 Feb;69(2):470-481.e2. doi: 10.1016/j.jvs.2018.05.255.
5
Cost Analysis of Initial Treatment With Endovascular Revascularization, Open Surgery, or Primary Major Amputation in Patients With Peripheral Artery Disease.外周动脉疾病患者血管腔内血运重建、开放性手术或一期主要截肢初始治疗的成本分析。
J Endovasc Ther. 2018 Aug;25(4):504-511. doi: 10.1177/1526602818774786. Epub 2018 May 14.
6
Peripheral artery disease: epidemiology and global perspectives.外周动脉疾病：流行病学和全球视角。
Nat Rev Cardiol. 2017 Mar;14(3):156-170. doi: 10.1038/nrcardio.2016.179. Epub 2016 Nov 17.
7
Epidemiology of Peripheral Arterial Disease and Critical Limb Ischemia.外周动脉疾病和严重肢体缺血的流行病学
Tech Vasc Interv Radiol. 2016 Jun;19(2):91-5. doi: 10.1053/j.tvir.2016.04.001. Epub 2016 Apr 22.
8
Nationwide Trends of Hospital Admission and Outcomes Among Critical Limb Ischemia Patients: From 2003-2011.全国范围内重症肢体缺血患者住院和结局的趋势：2003-2011 年。
J Am Coll Cardiol. 2016 Apr 26;67(16):1901-13. doi: 10.1016/j.jacc.2016.02.040. Epub 2016 Mar 21.
9
Trends in Procedure Type, Morbidity and In-Hospital Outcomes of Patients with Peripheral Artery Disease: Data from the Brazilian Public Health System.外周动脉疾病患者的手术类型、发病率及住院结局趋势：来自巴西公共卫生系统的数据
Ann Vasc Surg. 2016 Feb;31:143-51. doi: 10.1016/j.avsg.2015.08.019. Epub 2015 Nov 23.
10
A systematic review of lower extremity arterial revascularization economic analyses.下肢动脉血运重建经济分析的系统评价。
J Vasc Surg. 2011 Oct;54(4):1131-1144.e1. doi: 10.1016/j.jvs.2011.04.058.